Keyphrases
Long-term Safety
100%
Long-term Efficacy
100%
Glycerol Monostearate
100%
Urea Cycle Disorders
100%
Adverse Events
33%
Pediatric Patients
22%
Adult Patients
22%
Ammonia Level
22%
12-month Follow-up
22%
Hyperammonemic Crisis
22%
Safety Study
11%
Commercially Available
11%
Pediatric Population
11%
Europe
11%
Canada
11%
Long-term Evaluation
11%
All Ages
11%
Duration of Therapy
11%
Adult Population
11%
Glutamine
11%
Neuropsychological Tests
11%
Upper Normal Limit
11%
Patient-completed
11%
Ammonia Control
11%
Protein Restriction
11%
Amino Acid Supplementation
11%
Treatment-related Adverse Events
11%
Safety Signal
11%
Pharmacology, Toxicology and Pharmaceutical Science
Glycerol Phenylbutyrate
100%
Urea Cycle Disorder
100%
Adverse Event
44%
Amino Acid
11%
Glutamine
11%